Data Science Intern, Enveda
Undergrad ($1125/week), Masters ($1250/week), Phd ($1500/week)
More information about location
Drug discovery & development platform
Be an early applicant
Drug discovery & development platform
201-500 employees
Be an early applicant
Undergrad ($1125/week), Masters ($1250/week), Phd ($1500/week)
More information about location
201-500 employees
Company mission
To bring home to and improve the health of people everywhere.
Jump to section
Company mission
To bring home to and improve the health of people everywhere.
33% employee growth in 12 months
Our take
Despite massive innovations in healthcare of late, drug discovery is still an arduous process, and a huge amount of the natural world remains unexplored for medicinal molecules. Enveda Biosciences delivers a platform to rapidly probe for new medically active compounds, creating the world's "most diverse biologically annotated dataset of small molecules".
With Enveda's AI and ML-led technology, the chemical structure and biological activity of molecules can be assessed at speed and scale, using high-throughput experiments to generate the dataset that can be rapidly searched for new leads. This represents a breakthrough compared to the long and slow, classical drug discovery process which involves testing one molecule at a time.
Enveda Biosciences has seen substantial funding that is cited to help progress multiple platform-derived molecules to the clinic, allowing the company to apply its discovery technology to the drug development stages - with targets including inflammation, fibrosis, and neurosensory disorders. With investors including leaders in biotech and technology, it is clear the company is exciting the space and has the potential to make great impact in the future.
Freddie
Company Specialist at Welcome to the Jungle
Benefits
- Paid Parental Leave: 12 weeks for all parents.
- Adoption Assistance: Receive support in growing your family.
- Work-from-Home Stipend: Get what you need to do your best work.
- Work-Life Harmony: We believe people are human beings, not human doings. We work hard, but we rest hard too.
- Weeklong Company Break: The entire company closes for a week at the end of the year, to give everyone a chance to recharge.
- Flexible PTO: We encourage frequent use of your flexible PTO - and we celebrate taking breaks.
Funding (last 2 of 9 rounds)
Sep 2025
$150m
SERIES D
Feb 2025
$20m
SERIES C
Total funding: $521.8m
This company has top investors
Leadership
Viswa Colluru, PhD
(Founder & CEO)Spent two years at Recursion Pharmaceuticals, including a year as a Senior Product Manager of Assets and Translation.